# Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis

> **NCT07653750** · NA · TERMINATED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 62 (actual)

## Conditions studied

- Moderate to Severe Ulcerative Colitis

## Interventions

- **BIOLOGICAL:** Serum and fecal measurements

## Key facts

- **NCT ID:** NCT07653750
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-25
- **Primary completion:** 2026-06-09
- **Final completion:** 2026-06-09
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** We were able to test our hypothesis using the current data
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07653750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07653750, "Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07653750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*